Please login to the form below

Not currently logged in
Email:
Password:

Mirna Therapeutics

This page shows the latest Mirna Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Oncology bias in pharma deals

Silence Therapeutics and miRNA Therapeutics have also signed a collaboration to evaluate delivery of novel microRNA Therapeutics, via Silence's AtuPLEX and DBTC delivery systems. ... not known. Silence Therapeutics/ miRNA Therapeutics. R&D collaboration.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Mirna Therapeutics appoints new executive vice president Mirna Therapeutics appoints new executive vice president

    Mirna Therapeutics appoints new executive vice president. Miguel Barbosa willalso serve as chief scientific officer. ... Mirna Therapeutics has appointed Dr Miguel Barbosa as executive vice president and chief scientific officer.

  • Adaptimmune appoints Lawrence Alleva to its board Adaptimmune appoints Lawrence Alleva to its board

    He currently serves as a director for public companies Tesaro and Bright Horizons Family Solutions, and for the privately-held Mirna Therapeutics, and chairs those companies' audit committees.

  • Mirna hires former Pfizer director as CMO Mirna hires former Pfizer director as CMO

    Mirna hires former Pfizer director as CMO. Dr Sinil Kim has extensive experience in oncology. ... Dr Sinil Kim has left his position as a senior director at Pfizer to join Mirna Therapeutics as chief medical officer and senior VP, oncology.

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics